EIPICO manufactures over 400 pharmaceutical products covering 25 therapeutic classes, including antibiotics, lyophilized products, and spansule capsules. The company was established in 1980 and started production in 1985. EIPICO operates two factories and is in the process of completing its third facility, EIPICO 3, which is designed to produce biological and biosimilar products. EIPICO’s total exports amounted to about $52 million in 2022, constituting a market share of nearly 25% of total Egyptian pharmaceutical exports.